Shares of Insperity (NSP), a leading human resources and business performance solutions provider, plummeted 5.51% in pre-market trading on Friday following the release of its disappointing second-quarter earnings report and lowered full-year guidance.
The company reported adjusted earnings per share (EPS) of $0.26 for the quarter ended June 30, significantly below the analyst consensus estimate of $0.43 and down from $0.86 in the same period last year. Revenue for the quarter came in at $1.658 billion, slightly missing the expected $1.662 billion but showing a 3% increase from the previous year.
Insperity's performance was impacted by higher-than-expected benefits costs, primarily driven by elevated pharmacy trends and large claim activities. This resulted in a decrease in gross profit from $260 million in Q2 2024 to $223 million in Q2 2025. Adding to investors' concerns, the company lowered its full-year 2025 adjusted EPS guidance to a range of $1.81 to $2.51, down from the previous outlook of $2.23 to $3.28. This reduction in guidance, coupled with the earnings miss, likely contributed to the sharp decline in the stock price.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。